Ecolab Inc. Price & Performance (ECL)

At this time, all participants are in listen only mode.

The question and answer session will follow today's formal presentation. As a reminder, this conference is being recorded. At this time, it is now my pleasure to introduce your host, Andy Hedberg. Vice President, Investor Relations. Thank you, Mr. Hedberg. You may now begin. Thank you and hello everyone and welcome to Ecolab's fourth quarter conference call. With me today are Christophe Beck, eClub's Chairman and CEO and Scott Kirkland, our CFO.

A discussion of our results along with our earnings release and the slides referencing the quarter results are available on Ecolab's website at ecolab.com/investor Ecolab. [indiscernible] take a moment to read the cautionary statements in these materials, which state that this teleconference and the associated supplemental materials include estimates of future performance These are forward looking statements and actual results could differ materially from those projected. Factors that could cause actual results to differ are described under the Risk Factors section in our most recent Form 10 ks and in our posted materials. We also refer you to the supplemental diluted earnings per share information in the release. With that, I'd like to turn the call over to Christophe Beck for his comments.

Thank you, indeed, and welcome to everyone on the call.

As we wrap up another incredible year at Ecolab, I wanted to take a moment to acknowledge the hard work and dedication of our exceptional team.

Their unwavering commitment to our mission has been instrumental in delivering unmatched value and best in class outcomes for our customers, driving Ecolab's record performance. It's a true privilege to lead such a talented group and I'm proud of what we've achieved together over the last few years. 2024 was another record year for us. With record sales, record earnings record margins and record free cash flow, all supported by the exceptional As we look ahead to 2025 and beyond, our results position us well to continue delivering superior performance for both our customers and our shareholders. In Q4, our organic sales growth was solid. And steady at 4%, driven by consistent volume growth, and value pricing. Regionally, our performance continues to be led by The United States. Where organic sales grew mid single digits.

The United States makes up more than half of vehicle up sales and is our most profitable region. We expect this region to strengthen further in 2025. Fueling continued strong performance for Ecolab.

Sales across the rest of the world grew low single digits driven by resilient demand our leading solutions. Good new business wins, and value pricing. Which more than offset the uneven macroeconomic trends in these regions. Our organic operating income margin in the fourth quarter increased a robust 150 basis points.

This underscores our commitment to driving margins higher while making continued critical investments in sales firepower capabilities and capacity to fuel our future growth. For the full year, our organic operating income margin was 16.8%, up two ninety basis points on top of 140 basis points delivered in 2023.

With all of this, my confidence in reaching our 20% operating income margin target over the next three years continues to strengthen. As we move into 2025, I'm confident in Ecolab's ability to drive continued solid organic sales growth and 12% to 15% earnings growth. Our strategy centers on capturing market share through our Ecolab initiative, and accelerating momentum in our new growth engines specifically in data centers, microelectronics, life sciences and our newest offerings from Ecolab Digital.

Externally, currency translation unfavorable impact on Ecolab's 2025 reported sales growth and an approximate 4% unfavorable impact on adjusted EPS growth. We plan to mitigate the earnings impact in two ways. Through stronger value pricing, which is expected to be slightly higher than twenty twenty four's pricing, as the total value delivered to customers continues to expand. And true, through slightly faster than expected OneEcoLab savings. As a result, we look for continued superior performance in 2025 with adjusted diluted earnings per share expected to increase 12% to 15%. Even with organic sales growth improving slightly from the 4% we delivered in 2024. With a solid growth formula in place to deliver again in 2025. We also plan to build and invest in our business to feel continued strong performance for the years ahead. Two of these critical areas include Ecolab's Ecolab high-tech business and Ecolab Digital.

Our global high-tech business operates in the rapidly growing multibillion dollar data center and microelectronics industries. Sales in this business have reached over $300,000,000 and we expect strong growth to continue in the coming years with OI margins well above 20%. The rise of AI prompting data centers to rethink the cooling strategies, leading to a shift from air cooled to liquid cooled servers. This transition presents Ecolab with a significant opportunity to apply our extensive expertise in fluid management, microbiome control, high performance cooling which is one of our core Maximo's uptime and protect the substantial investments. Our new business pipeline in these markets is very strong. Driven by robust demand for our breakthrough innovation focused on high performance cooling for data centers and water circularity for microelectronic fabs. We're well positioned to leverage these innovations. Along with our leading digital applications and global sales and service expertise. To serve the world's largest technology companies. Ecolab Digital will also add to our momentum. By leveraging the power of our extensive digital and AI capabilities to across the 40 industries we serve.

Ecolab Digital manages more than 100,000 customer Last year alone, we captured more than 120,000,000,000 proprietary data points across these systems. This data was used to identify ways to deliver improved operational performance and profitability for our customers' global enterprises.

We're monetizing this enhanced customer value through patented device leases application subscriptions, and digital content consumption all of which is supported by Ecolab's global sales and service organization to make it work. As previously indicated, we'll begin to report our digital sales in 2020 to provide even greater transparency to these high growth high margin opportunity. To support these efforts, and our other growth engines, we will continue to accelerate smart organic and inorganic investments. With this, we expect our CapEx to sales to be around 7% in 2025.

As we continue to expand digitally connected systems, like our Ecolab three d Cloud, three d Trades are AI dish machine program, and pest intelligence. With our record free cash flows, and very healthy balance sheet, we are also in a unique position to take advantage of inorganic opportunities in water, digital and life sciences to deliver even more value to customers and attractive returns for shareholders. With these initiatives, we remain focused on further enhancing shareholder returns through increased dividends and share buybacks. In December, Ecolab's Board declared a 14% And in 2024, we bought back $1,000,000,000 of Ecolab stock very attractive prices. All signs of confidence in our team and in our future. Overall, I firmly believe the best of Ecolab is yet to come. Our ability to deliver innovative solutions that in improve our customers' operational performance while reducing the water and energy use is increasingly relevant in today's micro landscape. We're well positioned to deliver another stronger in 2025 and beyond. So thanks again for your continued support and your investment in Ecolab. I look forward to your questions.

Thanks, Christophe. That concludes our formal remarks. Operator, would you please begin the question and answer period.

Yes, thank you.

Thank you. Our first question is from line of Tim Maroney Scott, good afternoon. [indiscernible] So it sounds like your confidence around that 20% OI margin target by 2027 continues to go up. And it looks like the market is coming around to that idea as well based on the stock price today. I wonder if you could help us though think through the cadence of that expansion over the next three years And remind me about the primary drivers behind this. Thank you.

Great question. Thank you, Tim. So you're right. I feel we feel really good about getting to 20% by 2027, just to be accurate as well. Even though the exact timing will also depend on external factors. But we're talking quarters here, not you. So 2027 is for me the year where we should cross that 20% line. So why am I confident? Well, first, we've been on a steady trajectory for a few years now.

Our OI margin went up as mentioned earlier, so up 140 basis points in 2023. Two ninety basis points in 2024. We had 16.8% in 2024. And second, we focused on the right things to drive margins. It's top line momentum, which is pretty steady. I like it. Second, value pricing, solid didn't exactly know where it would land. So these 2% to 3% seems to be the sweet spot for us. Innovation keeps to add margin in a very steady way. And fourth, productivity driven by technology. So for 2025 with everything I know today, I think that we should cross the 18% OI margin this year. And beyond that, when I think about the new engines team that we are building, and fueling to accelerate momentum like the 20%, those businesses. Life sciences, underlying as well. We're investing behind it to really sell get ultimately so this north of 20% margin in the P and L but that's going to take a few years to get there. And last but not least, Ecolab, which is doing really well, which we will report in the first quarter as promised as well. While has very good margin as well at the same time.

So great track record so far focused on the right drivers to drive margins. So I feel good about crossing the 18% line in 2025. And with what we're building in terms of new businesses, ultimately, so we'll get the 20% by 2027. As I promised for a while now.

Our next question is from the line of Manav Patnaik with Barclays. Please proceed with your question.

Thank you. Good afternoon, Christophe. Apologize if I missed this, but I know you said you'll sizing it? And I suppose how intertwined is it with your one Ecolab initiative and the importance of that?

Yes. So I promised that we would be disclosing that in 2025. We want to do it obviously the right way. It's going to be top line in 2025 and it's going to be more of the P and L in 2026 hopefully that we can have numbers that you can trust that are transparent. It's all in the spirit of giving you as much visibility as we can. But today, it's a few hundred million we'll provide the exact numbers as we report the first quarter. It's high gross, high margin, high touch very sticky because it's a combination of mostly three things and it's purely digital. Like you would use with your iPhone or Samsung whatever you have Manav. Well, we get lease or rent for our devices. And we have 100,000 of those connections around the world. So it's first digital equipment, lease is second is software or think applications on a phone. But for us, it's software like Omni to improve optimize performance of a power plant for instance between the cooling tower the condenser, while we get the [indiscernible] of data, of transaction, of minutes of support, of emergency service and so on. So those are the three components that will be feeding our numbers that will be reporting under Ecolab Digital.

And last point, the relationship to One Ecolab, while it's very, very clearly intertwined, and on purpose, obviously, because all the information that we're getting with all our connected systems and our service data, by the way, that we kept from our field sales force or from our customers or from other systems, all feed into Ecolab three d, that ultimately provides data for the software and the consumption as well that's being used by our customers. So it's two sides of the same coin, but more to come at the end of the first quarter. So when we can really report our top line numbers.

Thank you. Next question is from the line of Ashish Sabadra with RBC Capital Markets. Please proceed with your question.

Thanks for taking my question. I just wanted to better [indiscernible] And if you could provide any color by segments as well as any impact any potential impact from tariffs? Thanks. And congrats on solid Thank you so much, Ashish. So if I understood, you're right. So the last part of your question was the impact of tariffs. So which is obviously a bit of a different topic here. But generally, with what we know now and it's an evolving proposition, as we know as well, we don't see a big impact on our business for a very simple reason. Is that 92% of what we sell is produced locally. And in places like China, it's 99% of what we sell is produced locally. So we're kind of well protected from a supply chain perspective. That's the reason why tariffs for now not a big deal for the company and hopefully it's staying so. And if it doesn't, I'd like to remind you and all as well online that a few years back, so we established that surcharge mechanism that we used for the energy spike in 2022. Well, this is a mechanism that in the extreme case we can use as well.

We're not planning to, but we prepared to use it if we need to. So kind of feeling good, about that tariff story. Now the first part of your question five way we need to think about it, not every quarter is created equal, but trajectory is basically so this around 2% volume growth. This is kind of the cruising speed we've had for a few quarters now. The price value price, $2.23, but better than in 2024. I believe which will lead to a 4% plus overall trajectory. So for 2025. That's kind of the top line expectation for 2025. That's for organic, obviously, and then you have an FX component for reported numbers. But last point I'll make two elements First, in terms of long term direct to refer what I shared with you almost two years ago by business in terms of top line and margins that invest today, those ones are still valid. No change. On this one. The last point is The United States is our largest market. It's over half our sales. It's our best performing market. With the highest margin, as well at the same time. Which is a good place to be in the world that we're living in right now.

And around the world, it's obviously different market by market. But generally, I feel good. All the markets are in a reasonably good place. Good profitability as well. We have no underdog as well out there. So pretty well balanced in terms of business performance and market performance at the same time, while The U. S. Is the leading market, which is a good thing nowadays. [indiscernible] question is from the line of John McNulty with BMO Capital Markets.

So I was just curious if you could give us some color or thoughts on how you're thinking about delivered product costs in 2025? It seems like there's a bunch of kind of puts and takes out there. So if you can give us a little bit of color on that, that'd be great.

Thank you, Joanne. I'll pass it to Scott, so he can work as well a little bit Thanks for the question, John. Yes, as we think about the DPC, as we started seeing in in 2024, where we're starting to see that the DPC tailwinds normalize and really turn to normal levels of inflation Our expectation going into next year as we talked about after Q3 is this normal level of low single digit inflation for builder product costs. But certainly, we will continue to offset as much of that with supply chain efficiencies, but that is our net expectation for DPC next year, it's low single digits.

Next question is from the line of Jason Haas with Wells Fargo. Please proceed with your question.

Hey, good afternoon and thanks for taking my questions and curious if you could talk about what it will take to get the 2% volume growth to the long term target of 3% to 4%? How much it How much of that is reliant on some of these industries you're in improving versus you can accomplish with OneEcosystem Lab and your other initiatives? Thank you.

It's our main focus Jason. So I feel good about what we're doing about it. You mentioned it's all about unlocking a bigger share of the $55,000,000,000 of penetration in existing customers that we have. And as mentioned, so separately, as Just our top 35 customers have a potential of over $3,000,000,000 of penetration as well. So, Juan Ecolab focused on our major customer partners, is the main driver of how much we can accelerate underlying growth as a company.

The second component is really those new engines.

Like I mentioned, in my open, so global high-tech with data centers and fabs, These are really interesting engines for the future. Life science is another one, Ecolab Digital, as mentioned, that we're going to start reporting at the top line levels of the Q1 will be one as well. And ultimately, really keeping improving the performance of our core businesses, institutional, pest elimination, our core water businesses, by focusing really on new business generation And I feel good with the trajectory that we're having, the backlog that we have in terms of new business. We need to install it So we have all the elements that we need in order to improve the performance at the volume level, but I'd like to make sure that we also look at volume plus value pricing because for us, as you know, value pricing is not [indiscernible] It's mostly wish you of the value that we deliver to our customers, which as a proxy is usually so [indiscernible] The pricing that our customers are paying for us. So it's a very good deal for our next question is from the line of Patrick Cunningham with Citigroup.

Please proceed with your question. Hi, good afternoon. Thank you for taking my question. This is Rachel Leon for Patrick. It looks like LifeSciences performed better And what is driving the underlying business momentum and the improving outlook in 1Q.

Thank you, Rachel. Light Science is a business that we started building in 2016, 2017, really focusing on on pharma, the acquisition of PURELIGHT in 2021, added really the ultra purification for the biotech world because we firmly believe that drug development, drug production, disease prevention is going to be and is a growth market long term. So feel really good about where the market is going to go. We know that the industry had to go through a bit of a transition or the past few years, but it doesn't change where we're coming from, and it doesn't change where we're going. It's just a few years of transition During those few years, we've kept growing. As well, not as fast as we were hoping, but our competition was declining. During that time.

So feel pretty good as well about that. But the last few years, we've built new capabilities plants, systems, quality systems, we've strengthened our team as well in dramatic ways, which is something that Ecolab is very strong at. So I feel really good about the industry we serve, how we serve that industry in being the smaller player very agile, very innovative, very respond very close to customers, and the capabilities that we have built for the future and we see early fruits coming out, which is a very good sign. So I feel good about where we are, where we're going with Life science. It's not going to be a straight line to have an for the quarters to come, not every quarter is created equal. But the direction of travel is good and we keep getting better. The next question is from the line of Vincent Andrews with Morgan Stanley.

Please proceed with your question.

Thank you. I'm wondering if you could talk a little bit more about sort of the leverage point. It looks like you're going to get to maybe it's in both data centers.

And in pet where you've had to make some meaningful investment to go after that business and it's kind of more of a percolates in the backlog for a while, before it actually shows up in revenue. So maybe you could just help us understand where you are in terms of the level of spend that you've had to make versus starting to see a real ramp up or an inflection in the volume and therefore therefore the margins that new volume will drive as the volume is becomes greater than the spend.

Well, it's already a good business with good margins, so to begin with. So we are investing behind these two businesses, data centers and fabs, but not in crazy ways.

It's to do it in a smart way, in a typical Ecolab Ecolab, that it's pay as you go, even though it's a little bit more than we would normally, it's not much more So it's done in a very healthy way. And to your question of how far are we down that journey, Well, it's early because it's early for everyone. The very good news is that it's new technologies that nobody has truly developed yet. And I think that we are best positioned for that. The way we present it internally I might get a little bit ahead of my skis here.

You have NVIDIA that's developing the best chips in the world. You have ASML producing the machines to produce the chips You have TSMC and Samsung producing the chips. And you will have us providing all the cooling technology and the water recycling in the fab. Two comments on that.

On data centers technology today. While you have a lot of computers in a room that's cooled with air conditioning, we're very strong at that. We know how to master that. While the new generation now is directed cheap cooling. So you have a cold fluid going to the chip. Well, that's a very different technology Can imagine, so bringing that fluid to the chip, all the challenges of scaling of fouling, of managing all that in real time. This is what three d TraceR was made for initially. So we uniquely placed in terms of technology, so close to chip managing that fluid and cooling that fluid as well at the same time. Feel really good with the developments that we've made and very close to some of the largest tech companies out there. So all the big names are working pretty closely to us. And the last point, for the fabs, one fab just for perspective is using an equivalent of drinking needs of 17,000,000 people. So that can't go forever. Because obviously we won't have enough water in order to feed all those fabs while feeding people as well at the same time. So we need technology to reuse and recycle water within the fab which is exactly what we're doing.

And we're having some very good development projects with very famous tech companies as well out there. So it's early. Because the industry is early, but I think that we are the leading edge and we will be the ones hopefully leading for the years to come as well. The next question is from the line of John Roberts with Mizuho Securities.

Please proceed with your question. Mr. Roberts perhaps your line is on mute.

Sorry about that. In the pest elimination segment, could you discuss the accidents that you had? And how much of the earnings headwind was the accidents versus the increased spending on pest intelligence? Yes. First, we are an extremely safety focused organization. As you know, John saw my first thought is really about the people and the families who have been hurt. We have some very good safety records really at world class levels. So when when a few accidents happen, you can see in the records, you can see it in our cost evolution as well. So the OI decrease that we had, so the majority of it was driven by the accidents. This is something that we're working on. We're very focused on. It can happen even though we are having that objective of goal zero. In every business, every function, anywhere around the world. And when it happens, we deal with it. And that's exactly what happened. And fortunately, in pest elimination, we need to live with it but most importantly, we need to address it.

Thank you. Our next question is from the line of Shlomo Rosenbaum with Stifel. This is the Hi. Thank you very much. I wanted to ask if you could just unpack the CapEx a little bit. We talked about some investments into digital and some of the other areas. CapEx typically for the company was 5%. It moved up to a little over 6% last year and we're talking about 7%. Are we into a new normal type of kind of business model or is there something that there's a short term increase in investment or acceleration of investments?

And let me pass it to Scott, and I'll comment after that.

Hey, Shlomo. Yes, thanks for the question. As you know, cash said, historically, we've been in this percent to 6% range, but just to ground you, about half of that CapEx as percentage of sales is related to customer equipment. So customer equipment locations, so as we're growing CapEx will grow and as we move to that 7% in 2025, as Christophe said, we're continuing to invest and we're growing. So as sales accelerate, we'll continue to invest there. But in addition to that, we have programs that he has mentioned around, AI dish machine, which you may have seen at some of our shows, the pest intelligence, which we've referenced as well as the digital investments that Christophe talked before. So those programs that themselves as we accelerate in the near term certainly in 2025, I would expect possibly a little bit more elevated in 2026, but I don't think this is a long term trend, above 7%.

So it's not the new normal. But we have very strong cash flow, a very strong balance sheet, very good growth opportunities. Well, I want to leverage the capital that we have also to feed those growth opportunities. While we return cash to shareholders as well at the same time and keep the strong balance sheet that we have. So all in all, pretty healthy investments.

Thank you. Our next question comes from the line of Steve Byrne with Bank of America. This is Steve Byrne with Bank of America. Yes.

Thank you.

In order for your customers to utilize your products, whether it's in waste whether water treatment, laundry cleaning, dishwashing, pest elimination, all of that equipment that they have How much of it does VicoLab own or that you've sold to them or you have installed, is this part of the loyalty and pricing power that you have with those industrial It's a great question, Steve. We own virtually all of it and we want to keep it that way because it's proprietary new technology. It's much more sticky. This is good for us, but it's also good for the customer. Because they always get the latest technology, the upgrades, in software. They might pay for the new subscriptions for the new software as well. But generally, dispensing equipment, digital technology, all of that belongs to us. Our next question is coming from the line of David Begleiter with Deutsche Bank.

Please proceed with your question.

Thank you. Christophe, on the $25,000,000,000 growth this 2%, is that faster than the market And if it is, how much faster than the market is It is clearly faster than the market. You take the example of institutional. 6% growth in a down market. And you can look at different ways of looking at it. But the food traffic is down. So we're clearly gaining share This is true in our water business as well at the same time. I feel really good about the share that we're gaining. The 2% is kind of the steady volume growth that we have. Our focus is to keep working on it, to accelerate it. As I mentioned before, it was well, with our growth engines, with capturing more share of the EUR55 billion by leveraging One Ecolab adding digital as well. So all feeding into stronger than 2% for the long run. But we want to do it in a very smart way. I will never trade volume for price. And as you know, so we have strong value price as well. So it's keeping that equation in a good balance and that's why you don't see so big swings around these two.

We want to really do it in a very steady way that ultimately you can trust.

Direction of travel that we're having. Next question is from the line of Jeff Zekauskas with JPMorgan.

Please proceed with your question.

Thanks very much.

I have a three part question, but I think your answers will be brief. If you compare industrial and institutional in the [indiscernible] Which segment grew its volumes? [indiscernible] In terms of your 20% [indiscernible] It turns out that in 2027, your amortization costs will drop from today's level up by about $150,000,000 So your EBIT margin will go up about 90 basis points, but it won't affect your EBITDA margin.

So when you have that 20% margin target, does that include the drop in amortization? Or is your EBIT target really $21,000,000 and it doesn't take that into account?

And then lastly, in pest elimination, what exactly happened? [indiscernible] Ecolab employees insured or customers insured?

And why is this something which seems to have an effect over the next several quarters? Thanks.

So Jeff, you paid for one question only, but I'm going to give you sort of two bonus questions as well as a good friend. So first, the volume difference between disclosing, so volume and price, especially for competitive reasons, So I can't really answer that question. But in both cases, it's pretty good. So I feel good about the balance volume and price, which is something as mentioned before, that I want to keep a very good balance of. And you can see it at the overall company level. Second question, amortization is Not.

Included in 2027 there.

So when amortization of the exist thing obviously, so acquisitions that we've made, so it comes off the book, that's going to be on top. But I'm not counting that. So to get to the 20%, And third one, in pest elimination, it's always a combination of two, its insurance cost So depending on who owns the accident, while we have to pay, it's been unfortunate accidents as you know in pest elimination. We have a few thousand people on the roads 20 fourseven in sometimes remote places, in sometimes difficult customer locations as well. So it's been unfortunate, It happens. It was mostly in Q4.

There's going to be a little bit in Q1, but that's it. Our next question is from the line of Laurence Alexander Jefferies. Proceed to your question.

Good afternoon. Could you give us sense of your assumptions for 2025 around SG and A leverage taxes, interest expense and buybacks.

Let me give it to Scott as well.

Scott?

Yes, I got that.

Thanks, Lawrence.

I guess a three part question reminds me if I've read any of the three parts. But as we think about SG and A, as we talked about previously, we expected in our guide for next year to be at this 20 to 30 basis points of leverage and that's net of continued to invest in the business. Now certainly with the impact of FX that will have an impact on that. But as we accelerate the OneEcoLab savings as well, we still expect to be in that range of 20 to 30 basis points on SG and A leverage, but probably near the lower end of that range. In Q1, I would expect it to be slightly negative because as you can expect, the FX we're already seeing and it'll take some time to realize the savings aggressively throughout the year.

And then as we talk about taxes, so this year, we landed the full year in between our 2019 and 20% expectation for the year landed at 19.3 on an adjusted tax rate for the full year. And expect to be in this 20% to 21% range next year as we continue to drive earnings growth. So that earnings growth will sort of naturally get us closer to The U. S. Corporate rate, especially given the strength of growth in our U. S. Business.

And then lastly, on buybacks, I would just say, as Christophe mentioned before, the balance sheet is in a very, very good place. No change to our philosophy [indiscernible] you ended the year at a net leverage of about 1.7 times We repurchased that includes repurchasing about $1,000,000,000 a shares in 2024. And then future buybacks are really going to be dependent as it always has been on our investment opportunities including M and A. So with the balance sheet strength that we have, it gives us a lot of opportunity to invest both inorganically and organically and you'll see that in the CapEx as we talked about this increase to 7% of sales. So as I have right now, I would expect normal levels of buybacks, but consistent with our historical capital allocation philosophy and we will invest in the business as a number one priority.

Our next question is from the line of Chris Parkinson with Wolfe Research. Please proceed with your question.

Great.

Thank you so much. Just what I'm thinking about the Water segment and looking at the growth light downstream heavy and mining, Just given the long term outlook in data centers, microelectronics, some of the things you're obviously already betting from and obviously growing a more significant baseline. Is there just a general mathematical equation that would get us to, let's say, more of a mid single digit like the 5% or 6% growth rate especially the 2% pricing that you foresee for like 26% or 27%, just what's the best way to triangulate that over the long term because it seems like some momentum is beginning to build there? Thank you.

Yes. Well, you're right. So the industry also had to go through a lot of value price as you know. So over the last few years, the team did an [indiscernible] especially so keeping customers. We have these core principle as a company that we keep customers for life and we've done that very well over the last few years. The shift of gears that industrial did almost a year back now, well, has been to focus on businesses like Global High-tech with the data centers, with the fabs that are picking up speed. So when you look at the 1% to 2% to 3% in industrial, it's a big business, obviously. So you have some fast growing businesses in there and some less fast growing businesses as well. So within water, but the global high-tech which is $300,000,000 plus today, while growing pretty fast at very high margin is going to influence the overall industrial profile in the midterm as it grows in importance versus the size of the overall business. So if you've liked industrial, which we call water, by the way, so as of 2025 in the past, you'll like it even more in 2025 and in the years to come because our presence in those two big sectors is going to be critical.

In the future. And the other businesses as well. In food and beverage and in downstream, and in paper, they're all doing some really good work. As well as to improve the core performance. Of those older businesses, if I may say. A combination of older businesses, core businesses, strong, solid and in improving and on top of it, the new engines are adding to the steam as well. Will be a good equation long term for industrial. Our next question is from the line of Josh Spector with UBS.

This is he with your question.

Hey, guys. Congrats on a good quarter. This is James Cannon on for Josh.

Just wanted to touch on with some of the moving pieces that happened in the healthcare web sciences business.

Can you just level set for us kind of how much is moving from healthcare in [indiscernible] the institutional segment, what that kind of does on a margin profile?

And what the remaining standalone Life Sciences business looks like?

Yes, you will see more obviously as as we report the first quarter. Healthcare is [indiscernible] roughly $500,000,000 of sales at pretty low margin and that's going to move. So into the INS group.

It's going to have an impact probably of one percentage point top line and one percentage point margin. That's basically what's going to happen. Optic Obviously, the businesses themselves don't change. It's just the math that's regrouped healthcare within INS. But INS very strong, very healthy and the leverage that we are creating between healthcare and and institutional, well, is going to be beneficial for both. Ultimately. So INS is still going to be 20% OI type of business, so very healthy, very steady and it's going to keep getting better in the future. On the Life Science side, well, you'll see the exact numbers at the end of the first quarter. But it's between €500,000,000 and €1,000,000,000 in sales. We're investing quite heavily in that business. Underlying performance of OI of Life Science is in the mid-20s. But with what we invest is more in the low to mid teens today. But it's really keeping in mind, we're building capabilities, capacities, teams, systems, innovation, to build the business that's north of 25% and hopefully at some point north of 30% as well. So very pleased with what we're doing. And ultimately, we're having that as a separate reporting segment for you to have the transparency, the visibility of what's happening, what we're doing and where we're heading because I firmly believe that life Science is going to be a terrific business for us going forward.

Next question comes from the line of Kevin McCarthy with Vertical Research Partners.

Please proceed with your question.

Yes. Thank you and good afternoon. Maybe a two part question Christophe, would you comment on the relative margin differential between your U. S. Businesses and your international businesses and whether that's stable or narrowing or widening And then secondly, a question on your foreign exchange guidance.

Why is it the case that currency is expected to be a larger drag of 4% on your bottom line relative to 3% on the top line.

So let me have maybe Scott start with the second part of your question. And he might add on the first part as well and I'll build on it. Why don't you start, Scott?

Yes, Kevin, the simple answer. First of all, it's a pretty small difference. We're talking 3% on reported sales and 4% impact of translation FX. On EPS. So pretty small difference, but the simple answer it's just a result of geographic mix is the simple and obvious answer.

And on the OI margins, so the The U. S. Is is above average of the company, and outside The U. S. Is below average of the company, but not that much. Actually. It used to be way lower a few years back and today pretty close. Both are improving The 20% OI margin, by the way, at the market level, is the same objective for everyone around the world. Some markets have crossed that line already and everyone in the company is having that objective and trying to get beyond the 20% in all of the 11 markets that we have around the world. So generally, pretty healthy across the planet and I really like where we are.

Our next question is from the line of Justin Hoppe with Baird.

Please proceed with your question. It looks like right around $100,000,000 on it in 2024, quarters. And so I guess I'm just curious [indiscernible] dollars that's still the right number? Front loaded and everything or is that number going to move a little higher? Yes, let me pass it Scott. You were breaking up, so it was a bit hard to hear you. But what we understood was the pacing of the savings for the OneEcolab initiative So let me have Scott answer that question. And if it's not, what you had in mind, so please just ask again making sure that we answer what looking for?

Yes. So Justin, on the program, I just want to first start by saying, of course, as we've talked, this program is really about enabling the sales growth. That is the primary purpose. Accelerating that path to the 5% to 7% and taking advantage of this $55,000,000,000 cross sell opportunity that we've talked about But as you said, the program included $140,000,000 of savings, which we expected and talked about last year after in Q3 when we rolled out the program that we'd expect that to be pretty proportionate, pretty even. Over the first three years over the three years of the program.

Of course, if you take that $140,000,000 of savings, again, that's like averaging 1% of sales a year. So again, the big impact is not on SG and A, the big impact is not on SG and A, but on driving the sales growth. But within that savings, it's going to allow us to continue to invest in the business and that pacing, as we've reacted to the FX and just driven that program, we're expecting it to be a little bit more front loaded whereas you'd expected a third, a third, a third previously, we're probably expecting 40% to 50% of that savings to happen next year in 2025.

And I'd like to build on what Scott just said. So two things on OneEcolab. So it's clearly a growth initiative. The fact that savings are coming in better and faster is a very good sign. And it's a very good sign of adoption by our team and our customers. It's not that we cutting or doing some weird things here. It's a performance project to accelerate growth and it's important to keep it that way in mind. So that's the first part.

Improving faster than expected, which is really good. And second, from a growth perspective, the best example is in our F and B business, where one Ecolab has been leveraged in the last few months bringing hygiene and water together as one offering of our customers. This is working really well. You've seen the results of F and B are improving as well at the same time. So it's really showing that the one Ecolab initiative, which has been an old dream in a way, is really hitting on both fronts. [indiscernible] and growth cycle generation, which is exactly encouraging early signs of success.

Our next question is from the line of Andre Sastanovs with Barner.

Hello. I want to ask about the acceleration in the charges for the application implementation.

Of 01:00. It seems that we are close to €100,000,000 in 2024 out of €225,000,000 that was budgeted by 2027. So my question is, is there a risk this will run over budget?

No, not at all. Just to answer your question really simply, as we talked about, we've had great execution. We're accelerating the program. Just naturally the cost will be more front loaded because you recognize the accounting for the cost earlier and then the savings happen over time. And once you identify where those cost savings are going to be. So that is natural in every program that we've restructuring program that we've had. But again, because we're accelerating savings next year, seeing some of that, those costs are a little bit front loaded. But in terms of the returns, and the payback on the program itself, we will not see any difference.

Our next question comes from the line of Mike Harrison with Seaport Research Partners. Please proceed with your question.

Hi, good afternoon. In terms of the healthcare business going under the institutional segment, I was curious, is this basically just taking the operational changes you've made and now formalizing it into your financial reporting structure, Or are there some additional changes happening to how you're running that business and integrating that more the institutional approach.

No, it's exactly what you said, Mike. It's if you remember, so on healthcare, I've made a commitment to solve that business, which means getting this business to a place which is creating value for shareholders. We had a few steps The first one was getting the cost structure right. The second was the bifurcation of surgical versus infection prevention. The third was to sell the surgical drapes business. We've done that very successfully so. It's a done deal. By the way, it worked out really well with the carve out and sales to Medline worked out really, really well. And the last step was to leverage institutional because we have institutional with a huge critical mass is especially in The U. S. Serving so many locations, where you bring obviously the institutional service in in the food service, in the hospitality part, and then bringing infection prevention was a very natural add to serve hospitals the best possible way. So getting those two together reported in the same segments made a lot of sense because that's the way we will operate. Going forward. So that's the way we need to report as well at the same time.

That being said, as I've mentioned, the future of healthcare will be in instrument reprocessing. This is kind of a dish machine business, obviously, at the higher standard because it needs to be disinfected or sterile depending on the instruments that you are processing here. It's a business model that we know extremely well. We know how to make money with it as well. We have the capabilities, we have the reach, we have the footprint. For it as well. So that's going to add to it. But again, a business that's very similar to what we do in institutional in these rooms, just for different types of equipment at a different standard of cleaning as well. So I feel pretty good with the evolution that we've gone through with our healthcare business.

Finally, it was time, obviously, to get to the right place. But I think that we're in the right place and heading in the right direction too.

Our next question is from the line of Scott Schneeberger with Oppenheimer.

Please proceed with your question. Thanks very much. Good afternoon. Yes, I have two.

Say them both upfront. On the digital pest intelligence program, Christophe, how long is the investment cycle there? Is that quarters, years and when and how will we see the benefits reflected? Will it be top line?

Margin? Just curious what we should see down the road? Thanks. And then on the follow-up, just on cross sell, could you talk about where you are with cross sell, particularly your top 35 customers? As you enter 2025, how meaningful can that be? Thanks.

Hey, thank you, Scott. So two very different questions, obviously here. The pest intelligence timing, when you think about it, it's thousands of people. It's millions of devices that you need to shift from analog to digital. This is something we know very well how to do. But this is physical work beyond the digital component. Obviously. So it's going to take sometimes I think it's going to be a few years but we're going to do it in a smart way as we've always done. It's in a pay as you go type of approach in a very typical ecola manner. As I mentioned, before, as well here, we can afford it because of the strong cash generation that we have as a company. The strong balance sheet that we have, the strong [indiscernible] So we might have some slight reduction of margins. So for a while as we did, with Life Science to make sure that ultimately we end up a margin that's even better than where we were and where we are as well today. So a few years but it's going to be done in a very healthy manner There will be no big shock, no big surprise and we will with you the progress that we're making and so far so good.

Some of the key customers, well, one of them is probably the largest retailer in the world, which has been our main partner to develop that solution, is almost done progressing very well. We have much better results as well at every retail location in The U. S. The customer very happy. We've learned a lot during that path as well. We had to adjust a few things. We still have to do it as well. We're learning with them, but it's the right partner. For us to develop the solution of the future. So so far so good. Now your second question on cross sell, which is the One Ecolab initiative. So it's capturing our fair share of the €55,000,000,000 cross sell or penetration opportunity that we have, as mentioned, the top 35, we have a 3,000,000,000 opportunity as well out there. Well, F and B, as mentioned before, is a perfect example of a business benefiting so from it because many of their customers are in those top 35 as well. We see the performance improvement in F and D is coming from there. For most of those 35 customers, we have focused plans that are enterprise wide plans Ecolab wide and customer wide as well at the same time.

Where we know ultimately what's the best in class performance. As I've shared with you, it's really for each of those 35 customers that we can help them understand what's the best in class performance in terms of business outcome, cost performance, environmental impact. And the difference between best in class performance and every of their location, what translates into the max dollar potential that we can get or that they can get and we have plans to get this off within the next few years, very well received by customers because they see ultimately better products, better cost profile, and lower impact on the environment. While it's hard to beat, it's especially when you can do it at a high return. Which means higher TV deals and the pricing they're paying for it as well. So, so far so good progress and the best is to come.

Thank you. Our final question is from the line of John Roberts with Mizuho Securities. Please proceed with your question.

It's been answered. Thank you.

That was a quick question, John. Well, thank you. So to to everyone. Really like the record performance that we delivered in 2024. The world is a bit complex in 2025. But feel really good with our plans, how we've started the year delivering this $12,000,000 to $15,000,000 which was our commitment, my commitment, So feel good for 2025. And most important play I feel even better for where we're going beyond '25 with data centers, with microelectronics, with life science, with Ecolab Digital and ultimately with the best team in the industry and that's what makes me believe even more in our future and we will deliver as we've always done.

Thank you. That wraps up our fourth quarter conference call. This conference call and the associated discussion slides will be available for replay on our website. Thank you for your time and participation and hope everyone has a great rest of the day.